Pruritus linked to wide variety of cancersSeptember 16, 2018Medical DermatologyIndolent LymphomaAMLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic CancerB Cell Lymphoma
Venetoclax label now includes MRD dataSeptember 12, 2018CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
TP53 mutation plus complex karyotype equals poor prognosisSeptember 10, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
ASCO updates guidance on prophylaxis for adults with cancer-related immunosuppressionSeptember 7, 2018Patient & Survivor CareIndolent LymphomaHematologyOncologyInfectious DiseasesB Cell Lymphoma
Novartis nabs first CAR T approval in CanadaSeptember 7, 2018ALLAggressive LymphomasImmunotherapyFollicular LymphomaB Cell Lymphoma
RESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patientsSeptember 6, 2018CLLAggressive LymphomasLymphoma & Plasma Cell DisordersHematologic Malignancies
England green-lights coverage of one CAR T-cell therapySeptember 6, 2018Business of MedicinePractice ManagementImmunotherapyALLCellular TherapyAggressive LymphomasB Cell Lymphoma
Researchers find drug target in anaplastic large-cell lymphomaSeptember 6, 2018T Cell LymphomasAggressive Lymphomas
Rituximab/lenalidomide similar to rituximab/chemotherapy for follicular lymphomaSeptember 6, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Adverse events outweigh promise of SGN-CD70A against NHLAugust 30, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
New BTK inhibitor under review in ChinaAugust 29, 2018Mantle Cell LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
European Commission approves first CAR T-cell therapiesAugust 28, 2018ALLPediatricsLeukemia, Myelodysplasia, TransplantationAggressive LymphomasImmunotherapyB Cell Lymphoma
ctDNA predicts early outcomes in DLBCLAugust 27, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
FDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemiaAugust 27, 2018Indolent LymphomaLymphoma & Plasma Cell Disorders
Combo treatment yields MRD-negative remissions in CLLAugust 23, 2018CLLLeukemia, Myelodysplasia, TransplantationAggressive LymphomasLymphoma & Plasma Cell Disorders